Janssen and Stop TB Partnership to expand access to tuberculosis medicines
Wednesday, April 30, 2014
Janssen has entered into a new agreement with the Stop TB Partnership that will facilitate access to tuberculosis therapies in a number of poorer countries.
The novel collaboration has been agreed with the Stichting International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to a new anti-tuberculosis medicine from Janssen.
More than 130 low and middle-income countries outside of the US will then be able to obtain the medication through a procurement practice established by the GDF and IDA.
- Health Care